NCIC Clinical Trials Group clinical trials
Listed in the registry as: Research network.
The registry lists 116 studies whose lead sponsor is NCIC Clinical Trials Group. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 27, 2026.
Focus areas
Conditions NCIC Clinical Trials Group leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 116. Browse all 116 →
- Letrozole After Tamoxifen in Treating Women With Breast CancerCompletedNCT00003140Phase 3
- Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast CancerCompletedNCT00066443Phase 1/2
- Bortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's LymphomaCompletedNCT00428142Phase 2
- Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by SurgeryCompletedNCT00482755Phase 2
- Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer PainTerminatedNCT00930332Phase 1
- Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple MyelomaCompletedNCT00049673Phase 3
- BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal CarcinomaCompletedNCT01830621Phase 3
- Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone MetastasesCompletedNCT01248585Phase 3
- Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast CancerCompletedNCT00083174Phase 3
- Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast CancerCompletedNCT00066573Phase 3
- Observation or Radical Treatment in Patients With Prostate CancerTerminatedNCT00499174Not applicable
- Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaCompletedNCT00078949Phase 3
- Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00795340Phase 3
- Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck CancerCompletedNCT00820248Phase 3
- PF-00299804 in Stage IIIB or Stage IV Non-Small Cell Lung Cancer Not Responding to Standard Therapy for Advanced or Metastatic CancerCompletedNCT01000025Phase 3
- A Study of PX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or ProgressionCompletedNCT01259869Phase 2
- Phase II Study of Interleukin-21 (rIL-21) vs Dacarbazine (DTIC) in Patients With Metastatic or Recurrent MelanomaCompletedNCT01152788Phase 2
- A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate CancerCompletedNCT01331083Phase 2
- Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast CancerCompletedNCT00005957Not applicable
- Single vs Multiple-Fraction Therapy in Treating Patients With Previously Irradiated Painful Bone MetastasesCompletedNCT00080912Not applicable
- A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and LeukemiaCompletedNCT01184274Phase 1
- Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT00346320Not applicable
- AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00265876Phase 1/2
- A Study of AT9283 in Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT01145989Phase 2
- 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell CarcinomaCompletedNCT00075660Phase 2
- Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's LymphomaCompletedNCT00443976Phase 1
- Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue SarcomaCompletedNCT00053794Phase 2
- Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal CancerCompletedNCT00079066Phase 3
- Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate CancerTerminatedNCT00651326Phase 3
- SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver CancerCompletedNCT00095992Phase 2
- A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed Mantle Cell LymphomaCompletedNCT01652144Phase 2
- Sorafenib in Treating Patients With Metastatic or Recurrent Prostate CancerCompletedNCT00093457Phase 2
- SB939 in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00504296Phase 1
- A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural MesotheliomaCompletedNCT01486368Phase 2
- Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple MyelomaCompletedNCT00305812Phase 2
- Perifosine in Treating Patients With Metastatic or Recurrent Malignant MelanomaCompletedNCT00053781Phase 2
- Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3CompletedNCT00688246
- AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's LymphomaCompletedNCT00390117Phase 1
- Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate CancerCompletedNCT00054106Phase 1
- AEG35156 and Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Solid TumorsCompletedNCT00372736Phase 1
- Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast CancerCompletedNCT01138384Phase 1/2
- AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal CancerCompletedNCT00343408Phase 1
- SB939 in Treating Patients With Recurrent or Metastatic Prostate CancerCompletedNCT01075308Phase 2
- AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)CompletedNCT00107250Phase 1
- Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma MultiformeCompletedNCT00387400Phase 1
- Bortezomib in Treating Patients With Mantle Cell LymphomaCompletedNCT00030875Phase 2
- OGX-011 and Docetaxel in Treating Women With Locally Advanced or Metastatic Breast CancerCompletedNCT00258375Phase 2
- OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid TumorsCompletedNCT00471432Phase 1
- MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00869752Phase 1/2
- Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell LymphomaCompletedNCT00377052Phase 2